Gallic acid inhibits EMCV infection via targeting the interaction between TBK1 and IRF3 to promote IFN-β expression
Microbiology Spectrum · 2025
DOI: 10.1128/spectrum.01524-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Yan Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Gansu University of Chinese Medicine, Lanzhou, China. Hauptthemen laut MEDLINE: Gallic Acid, Interferon Regulatory Factor-3, Encephalomyocarditis virus, Interferon-beta. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Encephalomyocarditis virus (EMCV) is an important zoonotic pathogen with global distribution, which has caused huge serious economic losses to the development of the livestock industry. Gallic acid (GA) is an active ingredient of traditional Chinese medicine with wide pharmacological and biological activities and is also a potential antiviral drug. However, its antiviral effect and mechanism of anti-EMCV are still unclear. In the present study, we found that therapeutic administration of GA could significantly reduce the viral load and viral titer of EMCV to inhibit EMCV replication in a dose-dependent manner. GA could also protect cells infected by EMCV and decrease the content of capsid protein VP1 of EMCV in HEK-293 cells. Additionally, the mechanistic investigations revealed that GA might exert antiviral effects by regulating the interaction between TBK1 and IRF3 to promote the IFN-β expression. Meanwhile, GA could also alleviate EMCV-infected mice. These results indicate that GA may serve as a novel antiviral agent against EMCV infection. IMPORTANCE As a zoonotic pathogen, encephalomyocarditis virus (EMCV) causes myocarditis, encephalitis, neurological disease, reproductive disorders, and diabetes in pigs, which seriously endangers the development of the swine industry worldwide. However, due to the lack of effective commercial vaccines, there is an urgent need to develop safe and effective drugs against EMCV. Gallic acid (GA) has wide pharmacological and biological activities. However, the antiviral effect and the mechanism of GA are currently unknown. Here, we demonstrated that GA had a significant anti-EMCV effect. Further research found that GA inhibited EMCV infection via targeting the interaction between TBK1 and IRF3 to promote the IFN-β expression. These findings indicate that GA could be an effective anti-EMCV drug.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gansu University of Chinese Medicine, Lanzhou, China.
- Research Center of Traditional Chinese Medicine, Lanzhou, China.
- Key Laboratory of Biotechnology and Bioengineering of State Ethnic Affairs Commission, Biomedical Research Center, Northwest Minzu University, Lanzhou, China.
- School of Life Sciences and Engineering, Northwest Minzu University, Lanzhou, China.
ORCID-Profile: Yanqiao Wen, Ruofei Feng, Chunxia Tan
Zitieren
APA
Zhang, Y., Wen, Y., Xue, W., Zhang, T., Hou, J., Chen, X., Feng, R., & Tan, C. (2025). Gallic acid inhibits EMCV infection via targeting the interaction between TBK1 and IRF3 to promote IFN-β expression. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01524-25
Vancouver
Zhang Y, Wen Y, Xue W, Zhang T, Hou J, Chen X, et al. Gallic acid inhibits EMCV infection via targeting the interaction between TBK1 and IRF3 to promote IFN-β expression. Microbiology Spectrum. 2025. doi:10.1128/spectrum.01524-25
BibTeX
@article{Zhang2025,
author = {Zhang, Yan and Wen, Yanqiao and Xue, Weijiao and Zhang, Tengyu and Hou, Jixia and Chen, Xuewen and Feng, Ruofei and Tan, Chunxia},
title = {Gallic acid inhibits EMCV infection via targeting the interaction between TBK1 and IRF3 to promote IFN-β expression},
journal = {Microbiology Spectrum},
year = {2025},
doi = {10.1128/spectrum.01524-25}
}
EUVIMED